Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass

Speranza Rubattu, Sebastiano Sciarretta, Giuseppino Massimo Ciavarella, Vanessa Venturelli, Paola De Paolis, Giuliano Tocci, Luciano De Biase, Andrea Ferrucci, Massimo Volpe

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: The metabolic syndrome (MS) is associated with left ventricular hypertrophy (LVH). Previous evidence has shown that LVH is favoured by low levels of atrial natriuretic peptide (ANP), independently from blood pressure (BP), in hypertension. Although levels of natriuretic peptides are known to be lower in obesity, plasma ANP levels have not yet been assessed in MS. We aimed to assess the ANP levels and their relationship with left ventricular mass (LVM) in patients affected by MS. METHODS: One hundred and twenty-eight essential hypertensive patients were included in the study: 51 with MS and 77 without MS. Clinical, echocardiographical and biochemical parameters, and levels of both N-terminal (NT)-proANP and alphaANP were assessed. RESULTS: Hypertensive patients affected by MS had higher LVM and increased frequency of LVH. NT-proANP levels were significantly lower in MS, independent of waist circumference (WC). Log(NT-proANP) levels were significantly inversely related to left ventricular mass index (LVMI) (β = -0.360, P <0.001) and LVM/height (β = -0.370, P <0.001) in the whole hypertensive population by multiple linear regression analysis. The relationship of log(NT-proANP) with LVM was more enhanced in patients with MS. CONCLUSIONS: The present study demonstrates that levels of NT-proANP are significantly reduced in hypertensive patients affected by MS, and they are significantly inversely related to the increased LVM observed in these patients. Our findings, while supporting previous experimental and clinical evidence of the antihypertrophic role of ANP in hypertension, may help to identify one of the possible mechanisms directly underlying LVH in MS.

Original languageEnglish
Pages (from-to)833-839
Number of pages7
JournalJournal of Hypertension
Volume25
Issue number4
DOIs
Publication statusPublished - Apr 2007

Fingerprint

Left Ventricular Hypertrophy
Atrial Natriuretic Factor
N-terminal proatrial natriuretic peptide
Hypertension
Natriuretic Peptides
Waist Circumference
Linear Models
Obesity
Regression Analysis
Blood Pressure
Population

Keywords

  • Essential hypertension
  • Left ventricular mass
  • Metabolic syndrome
  • Natriuretic peptides

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology

Cite this

Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass. / Rubattu, Speranza; Sciarretta, Sebastiano; Ciavarella, Giuseppino Massimo; Venturelli, Vanessa; De Paolis, Paola; Tocci, Giuliano; De Biase, Luciano; Ferrucci, Andrea; Volpe, Massimo.

In: Journal of Hypertension, Vol. 25, No. 4, 04.2007, p. 833-839.

Research output: Contribution to journalArticle

@article{b02d9c216d6e4600a2f2d1970bbe96c9,
title = "Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass",
abstract = "OBJECTIVES: The metabolic syndrome (MS) is associated with left ventricular hypertrophy (LVH). Previous evidence has shown that LVH is favoured by low levels of atrial natriuretic peptide (ANP), independently from blood pressure (BP), in hypertension. Although levels of natriuretic peptides are known to be lower in obesity, plasma ANP levels have not yet been assessed in MS. We aimed to assess the ANP levels and their relationship with left ventricular mass (LVM) in patients affected by MS. METHODS: One hundred and twenty-eight essential hypertensive patients were included in the study: 51 with MS and 77 without MS. Clinical, echocardiographical and biochemical parameters, and levels of both N-terminal (NT)-proANP and alphaANP were assessed. RESULTS: Hypertensive patients affected by MS had higher LVM and increased frequency of LVH. NT-proANP levels were significantly lower in MS, independent of waist circumference (WC). Log(NT-proANP) levels were significantly inversely related to left ventricular mass index (LVMI) (β = -0.360, P <0.001) and LVM/height (β = -0.370, P <0.001) in the whole hypertensive population by multiple linear regression analysis. The relationship of log(NT-proANP) with LVM was more enhanced in patients with MS. CONCLUSIONS: The present study demonstrates that levels of NT-proANP are significantly reduced in hypertensive patients affected by MS, and they are significantly inversely related to the increased LVM observed in these patients. Our findings, while supporting previous experimental and clinical evidence of the antihypertrophic role of ANP in hypertension, may help to identify one of the possible mechanisms directly underlying LVH in MS.",
keywords = "Essential hypertension, Left ventricular mass, Metabolic syndrome, Natriuretic peptides",
author = "Speranza Rubattu and Sebastiano Sciarretta and Ciavarella, {Giuseppino Massimo} and Vanessa Venturelli and {De Paolis}, Paola and Giuliano Tocci and {De Biase}, Luciano and Andrea Ferrucci and Massimo Volpe",
year = "2007",
month = "4",
doi = "10.1097/HJH.0b013e32803cae3c",
language = "English",
volume = "25",
pages = "833--839",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass

AU - Rubattu, Speranza

AU - Sciarretta, Sebastiano

AU - Ciavarella, Giuseppino Massimo

AU - Venturelli, Vanessa

AU - De Paolis, Paola

AU - Tocci, Giuliano

AU - De Biase, Luciano

AU - Ferrucci, Andrea

AU - Volpe, Massimo

PY - 2007/4

Y1 - 2007/4

N2 - OBJECTIVES: The metabolic syndrome (MS) is associated with left ventricular hypertrophy (LVH). Previous evidence has shown that LVH is favoured by low levels of atrial natriuretic peptide (ANP), independently from blood pressure (BP), in hypertension. Although levels of natriuretic peptides are known to be lower in obesity, plasma ANP levels have not yet been assessed in MS. We aimed to assess the ANP levels and their relationship with left ventricular mass (LVM) in patients affected by MS. METHODS: One hundred and twenty-eight essential hypertensive patients were included in the study: 51 with MS and 77 without MS. Clinical, echocardiographical and biochemical parameters, and levels of both N-terminal (NT)-proANP and alphaANP were assessed. RESULTS: Hypertensive patients affected by MS had higher LVM and increased frequency of LVH. NT-proANP levels were significantly lower in MS, independent of waist circumference (WC). Log(NT-proANP) levels were significantly inversely related to left ventricular mass index (LVMI) (β = -0.360, P <0.001) and LVM/height (β = -0.370, P <0.001) in the whole hypertensive population by multiple linear regression analysis. The relationship of log(NT-proANP) with LVM was more enhanced in patients with MS. CONCLUSIONS: The present study demonstrates that levels of NT-proANP are significantly reduced in hypertensive patients affected by MS, and they are significantly inversely related to the increased LVM observed in these patients. Our findings, while supporting previous experimental and clinical evidence of the antihypertrophic role of ANP in hypertension, may help to identify one of the possible mechanisms directly underlying LVH in MS.

AB - OBJECTIVES: The metabolic syndrome (MS) is associated with left ventricular hypertrophy (LVH). Previous evidence has shown that LVH is favoured by low levels of atrial natriuretic peptide (ANP), independently from blood pressure (BP), in hypertension. Although levels of natriuretic peptides are known to be lower in obesity, plasma ANP levels have not yet been assessed in MS. We aimed to assess the ANP levels and their relationship with left ventricular mass (LVM) in patients affected by MS. METHODS: One hundred and twenty-eight essential hypertensive patients were included in the study: 51 with MS and 77 without MS. Clinical, echocardiographical and biochemical parameters, and levels of both N-terminal (NT)-proANP and alphaANP were assessed. RESULTS: Hypertensive patients affected by MS had higher LVM and increased frequency of LVH. NT-proANP levels were significantly lower in MS, independent of waist circumference (WC). Log(NT-proANP) levels were significantly inversely related to left ventricular mass index (LVMI) (β = -0.360, P <0.001) and LVM/height (β = -0.370, P <0.001) in the whole hypertensive population by multiple linear regression analysis. The relationship of log(NT-proANP) with LVM was more enhanced in patients with MS. CONCLUSIONS: The present study demonstrates that levels of NT-proANP are significantly reduced in hypertensive patients affected by MS, and they are significantly inversely related to the increased LVM observed in these patients. Our findings, while supporting previous experimental and clinical evidence of the antihypertrophic role of ANP in hypertension, may help to identify one of the possible mechanisms directly underlying LVH in MS.

KW - Essential hypertension

KW - Left ventricular mass

KW - Metabolic syndrome

KW - Natriuretic peptides

UR - http://www.scopus.com/inward/record.url?scp=33947099984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947099984&partnerID=8YFLogxK

U2 - 10.1097/HJH.0b013e32803cae3c

DO - 10.1097/HJH.0b013e32803cae3c

M3 - Article

C2 - 17351376

AN - SCOPUS:33947099984

VL - 25

SP - 833

EP - 839

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 4

ER -